CK Life Sciences Int'l

CK Life Sciences Int'l, founded in 2000, operates within the Business Services sector, specializing in the research, development, and commercialization of innovative biotechnology products and services. The company strategically focuses on delivering advanced solutions across healthcare, agriculture, and environmental protection, targeting pharmaceutical companies, agricultural businesses, and environmental organizations. Their core mission is to enhance the quality of life through sustainable and effective biotechnological applications, leveraging scientific expertise to address critical global challenges. With a commitment to innovation, CK Life Sciences Int'l aims to be a leader in the biotechnology field, driving progress through rigorous research and development initiatives.

The company's operational scale is significant, employing between 1,000 and 5,000 individuals. It generated a revenue of $679.6M, reflecting its substantial market presence and operational capacity. CK Life Sciences Int'l is publicly traded under the ticker HKEX: 775, indicating its status as a public entity. The organization's focus on specialized biotechnology solutions positions it uniquely within its industry. For insights into the people driving this innovation, one can Meet CK Life Sciences Int'l's team to understand their leadership and operational structure.

CK Life Sciences Int'l's product portfolio includes "life science" and "science" related offerings, underscoring its deep engagement with scientific advancement. The company's geographic footprint is primarily centered in China and the broader Asia-Pacific region, aligning with its operational base and market focus. Its commitment to sustainability and effective biotechnological solutions is central to its value proposition, aiming to foster advancements that benefit both human well-being and environmental health. The company's strategic direction isView more...